The polyamine transport system as a target for anticancer drug development

Amino Acids

Volumn 38, Issue 2, 2010, Pages 415-422

  Palmer, Andrew J ^a   Wallace, Heather M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Anticancer therapy; Polyamine transport system; Targeted drug delivery

Indexed keywords

ALKYLATING AGENT; AMINOACRIDINE; ANTHRACENE; ANTINEOPLASTIC AGENT; AZIRIDINE SPERMINE CONJUGATE; CAMPTOTHECIN POLYAMINE CONJUGATE; CHLORAMBUCIL; CYTOTOXIC AGENT; EFLORNITHINE; ETOPOSIDE; ETOPOSIDE SPERMINE CONJUGATE; F 14512; GEMTUZUMAB OZOGAMICIN; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE; SULINDAC; TOPOTECAN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; AMINE TRANSPORT; BINDING AFFINITY; BREAST TUMOR; CANCER INHIBITION; COLORECTAL CANCER; CONFERENCE PAPER; DNA BINDING; DNA VECTOR; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DNA BINDING; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; DRUG TARGETING; DRUG TRANSPORT; GENE TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; TRANSPORT KINETICS; VALIDATION PROCESS; ANIMAL; CHEMISTRY; METABOLISM; METHODOLOGY; NEOPLASM; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

HARNESS;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS; POLYAMINES;

EID: 77953072049     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-009-0400-2     Document Type: Conference Paper

References (48)

1. Bachrach U, Seiler N (1981) Formation of acetyl polyamines and putrescine from spermidine by normal and transformed chick embryo fibroblasts. Cancer Res 41:1205-1208
2. Barret J, Kruczynski A, Vispe S, Annereau J, Brel V, Guminski Y, Delcros JG, Lansiaux A, Guilbaud N, Imbert T, Bailly C (2008) F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system. Cancer Res 68:9845-9853. doi:10.1158/0008-5472. CAN-08-2748
3. Belting M, Persson S, Fransson LA (1999) Proteoglycan involvement in polyamine uptake. Biochem J 338:317-323
4. Belting M, Mani K, Jonsson M, Cheng F, Sandgren S, Jonsson S, Ding K, Delcros JG, Fransson L (2003) Glypican-1 is a vehicle for polyamine uptake in mammalian cells: a pivotal role for nitrosothiol-derived nitric oxide. J Biol Chem 278:47181-47189
5. Casero RA, Marton LJ (2007) Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov 6:373-390
6. Chari R V J (2008) Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc Chem Res 41:98-107
7. Cipolla B, Bansard JY, Moulinoux JP (2006) MP-22.06: phase I study of a novel polyamine free formula as nutrition therapy of metastatic hormone-refractory prostate cancer (HRPC) patients. Urology 68:196-197
8. Creaven PJ, Perez R, Pendyala L, Meropol NJ, Loewen G, Levine E, Berghorn E, Raghavan D (1997) Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancy. Investig New Drugs 15:227-234
9. Cullis PM, Green RE, Merson-Davies L, Travis N (1999) Probing the mechanism of transport and compartmentalisation of polyamines in mammalian cells. Chem Biol 6:717-729
10. Dallavalle S, Giannini G, Alloatti D, Casati A, Marastoni E, Musso L, Merlini L, Morini G, Penco S, Pisano C, Tinelli S, De Cesare M, Beretta GL, Zunino F (2006) Synthesis and cytotoxic activity of polyamine analogues of camptothecin. J Med Chem 49:5177-5186
11. Delcros JG, Tomasi S, Carrington S, Martin B, Renault J, Blagbrough IS, Uriac P (2002) Effect of spermine conjugation on the cytotoxicity and cellular transport of acridine. J Med Chem 45:5098-5111
12. Eiseman JL, Rogers FA, Guo Y, Kauffman J, Sentz DL, Klinger MF, Callery PS, Kyprianou N (1998) Tumor-targeted apoptosis by a novel spermine analogue, 1, 12-diaziridinyl-4, 9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer. Cancer Res 58:4864-4870
13. Eliassen KA, Reistad R, Risøen U, Rønning HF (2002) Dietary polyamines. Food Chem 78:273-280
14. Esteves-Souza A, Lucio KA, Da Cunha AS, Da Cunha Pinto A, Da Silva Lima EL, Camara CA, Vargas MD, Gattass CR (2008) Antitumoral activity of new polyamine-naphthoquinone conjugates. Oncol Rep 20:225-231
15. Gardner RA, Delcros JG, Konate F, Breitbeil F, Martin B, Sigman M, Huang M, Phanstiel O (2004) N1-substituent effects in the selective delivery of polyamine conjugates into cells containing active polyamine transporters. J Med Chem 47:6055-6069
16. Ghani RA, Palmer AJ, Kaur N, Phanstiel O, Wallace HM (2009) The polyamine transport system: a means of selective delivery of potentially toxic agents to cancer cells? Toxicology 262:13. doi: 10.1016/j.tox.2009.04.012
17. Holley J, Mather A, Cullis P, Symons MR, Wardman P, Watt RA, Cohen GM (1992a) Uptake and cytotoxicity of novel nitroim-idazole-polyamine conjugates in Ehrlich ascites tumour cells. Biochem Pharmacol 43:763-769
18. Holley JL, Mather A, Wheelhouse RT, Cullis PM, Hartley JA, Bingham JP, Cohen GM (1992b) Targeting of tumor cells and DNA by a chlorambucil-spermidine conjugate. Cancer Res 52:4190-4195
19. Le Roch N, Douaud F, Havouis R, Delcros JG, Vaultier M, Moulinoux JP, Seiler N (2002) Dimethylsilane polyamines: cytostatic compounds with potentials as anticancer drugs. II. Uptake and potential cytotoxic mechanisms. Anticancer Res 22:3765-3776
20. Love R, Jacoby R, Newton M, Tutsch K, Simon K, Pomplun M, Verma A (1998) A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer. Cancer Epidemiol Biomark Prev 7:989-992
21. Martinez ME, O'Brien TG, Fultz KE, Babbar N, Yerushalmi H, Qu N, Guo Y, Boorman D, Einspahr J, Alberts DS, Gerner EW (2003) Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarbox-ylase gene. Proc Natl Acad Sci USA 100:7859-7864
22. Mens T, Tomasi S, Eifler-Lima VL, Uriac P, Huet J, Catros-Quemener V (1997) Inhibition of tumor growth and polyamine uptake by tetracyclic amidines bearing a putrescine moiety. Anticancer Res 17:4327-4332
23. Meyskens F Jr, Gerner E, Emerson S, Pelot D, Durbin T, Doyle K, Lagerberg W (1998) Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J Natl Cancer Inst 90:1212-1218. doi:10.1093/jnci/90.16.1212
24. Meyskens FL Jr, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, Lance P, Hagedorn CH, Gillen DL, Gerner EW (2008) Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res 1:32-38
25. Palmer AJ, Ghani RA, Kaur N, Phanstiel O, Wallace HM (2009) A putrescine-anthracene conjugate: a paradigm for selective drug delivery. Biochem J 424 (3):431-438
26. Pang J, Long Y, Chen W, Jiang Z (2007) Amplification of DNA-binding affinities of protoberberine alkaloids by appended polyamines. Bioorg Med Chem Lett 17:1018-1021
27. Pastre D, Pietrement O, Landousy F, Hamon L, Sorel I, David M, Delain E, Zozime A, Le Cam E (2006) A new approach to DNA bending by polyamines and its implication in DNA condensation. Eur Biophys J 35:214-223
28. Phanstiel O, Price HL, Wang L, Juusola J, Kline M, Shah SM (2000) The effect of polyamine homologation on the transport and cytotoxicity properties of polyamine-(DNA-intercalator) conjugates. J Org Chem 65:5590-5599
29. Phanstiel O, Kaur N, Delcros JG (2007) Structure-activity investigations of polyamine-anthracene conjugates and their uptake via the polyamine transporter. Amino Acids 33:305-313
30. Porter CW, Miller J, Bergeron RJ (1984) Aliphatic chain length specificity of the polyamine transport system in ascites L1210 leukemia cells. Cancer Res 44:126-128
31. Quemener V, Blanchard Y, Chamaillard L, Havouis R, Cipolla B, Moulinoux JP (1994) Polyamine deprivation: a new tool in cancer treatment. Anticancer Res 14:443-448
32. Seiler N (2003a) Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect, Part 1. Selective enzyme inhibitors. Curr Drug Targets 4:537-564
33. Seiler N (2003b) Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect, Part 2. Structural analogues and derivatives. Curr Drug Target 4:565-585
34. Seiler N, Dezeure F (1990) Polyamine transport in mammalian cells. Int J Biochem 22:211-218
35. Seiler N, Delcros JG, Moulinoux JP (1996) Polyamine transport in mammalian cells: an update. Int J Biochem Cell Biol 28:843-861
36. Soulet D, Gagnon B, Rivest S, Audette M, Poulin R (2004) A fluorescent probe of polyamine transport accumulates into intracellular acidic vesicles via a two-step mechanism. J Biol Chem 279:49355-49366
37. Stasi R (2008) Gemtuzumab ozogamicin: an anti-CD33 immunocon-jugate for the treatment of acute myeloid leukaemia. Expert Opin Biol Ther 8:527-540
38. Suzuki I, Shigenaga A, Nemoto H, Shibuya M (2004) Synthesis and DNA damaging ability of enediyne-polyamine conjugates. Tetrahedron Lett 45:1955-1959
39. Volkow N, Goldman SS, Flamm ES, Cravioto H, Wolf AP, Brodie JD (1983) Labeled putrescine as a probe in brain tumors. Science 221:673-675
40. Wallace HM, Fraser AV (2004) Inhibitors of polyamine metabolism. Amino Acids 26:353-365
41. Wallace HM, Kerr HM (1982) A comparison of polyamine metabolism in normal and transformed baby-hamster-kidney cells. Biochem J 202:785-790
42. Wallace HM, Niiranen K (2007) Polyamine analogues: an update. Amino Acids 33:261-265
43. Wallace HM, Fraser AV, Hughes A (2003) A perspective of polyamine metabolism. Biochem J 376:1-14
44. Walters JD, Wojcik MS (1994) Polyamine transport in human promyelocytic leukemia cells and polymorphonuclear leukocytes. Leuk Res 18:703-708
45. Wang L, Price HL, Juusola J, Kline M, Phanstiel O (2001) Influence of polyamine architecture on the transport and topoisomerase II inhibitory properties of polyamine DNA-Intercalator conjugates. J Med Chem 44:3682-3691
46. Wang C, Delcros JG, Biggerstaff J, Phanstiel O (2003a) Molecular requirements for targeting the polyamine transport system. Synthesis and biological evaluation of polyamine-anthracene conjugates. J Med Chem 46:2672-2682
47. Wang C, Delcros JG, Cannon L, Konate F, Carias H, Biggerstaff J, Gardner RA, Phanstiel O (2003b) Defining the molecular requirements for the selective delivery of polyamine conjugates into cells containing active polyamine transporters. J Med Chem 46:5129-5138
48. Xie S, Liu G, Ma Y, Cheng P, Wu Y, Wang M, Ji B, Zhao J, Wang C (2008) Synergistic antitumor effects of anthracenylmethyl homospermidine and alpha-difluoromethylornithine on promye-locytic leukemia HL60 cells. Toxicol In Vitro 22:352-358